MedPath

Matthias Schwab

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:1

Trial Phases

2 Phases

Phase 1:2
Phase 4:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (66.7%)
Phase 4
1 (33.3%)

Open Label Study for the Functional Characterization of Drug Metabolism and Transport

Phase 1
Completed
Conditions
Genotype-related Drug Metabolism
Interventions
First Posted Date
2013-02-11
Last Posted Date
2015-05-27
Lead Sponsor
Matthias Schwab
Target Recruit Count
144
Registration Number
NCT01788254
Locations
🇩🇪

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany

🇩🇪

Abteilung Klinische Pharmakologie, Tübingen, Germany

Pharmacogenetic Factors and Side Effects of Metoclopramide and Diphenhydramine

Phase 1
Terminated
Conditions
Drug Metabolism, Poor, CYP2D6-RELATED
Interventions
First Posted Date
2011-02-04
Last Posted Date
2016-05-13
Lead Sponsor
Matthias Schwab
Target Recruit Count
49
Registration Number
NCT01289938
Locations
🇩🇪

Abteilung Klinische Pharmakologie, UKT Tübingen, Tübingen, BW, Germany

Omeprazole and Reflux Disease - Improvement of Clinical Outcome by Genotype-adjusted Dosing

Phase 4
Terminated
Conditions
Gastroesophageal Reflux
Interventions
First Posted Date
2007-10-01
Last Posted Date
2014-02-25
Lead Sponsor
Matthias Schwab
Target Recruit Count
68
Registration Number
NCT00537732
Locations
🇩🇪

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Baden-Württemberg, Germany

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.